# OnCo record regn7075 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/regn7075/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "regn7075" ;
  schema:name "REGN7075"@en ;
  schema:alternateName "EGFRxCD28 bispecific immunotherapy"@en, "marlotamig"@en ;
  schema:description "REGN7075 is a bispecific antibody from Regeneron Pharmaceuticals, in registered phase 2 trials for non-small-cell lung cancer, small-cell lung cancer."@en ;
  schema:url <https://onco.cc/drugs/regn7075/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=REGN7075> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Bispecific antibody" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/> ;
  onco:companies <https://onco.cc/companies/regeneron/> ;
  onco:trials <https://onco.cc/trials/nct06465329/>, <https://onco.cc/trials/nct07154290/>, <https://onco.cc/trials/nct04626635/> .